Table 1 |
||||
|
Antibodies used in Figure 5 and 5a summary of inter-set correlations |
||||
|
Antibody name |
RCA/direct (Figure 5a) |
RCA/indirect (Figure 5b) |
RCA/indirect (Figure 5c) |
|
|
|
||||
|
AB01 |
VAI00101 anti-cathepsin B (ab-1) |
-/- |
0.99/- |
0.83*/- |
|
AB02 |
VAI00194 anti-von Willebrand factor |
0.94/0.99 |
0.94/0.8 |
0.79/0.6 |
|
AB03 |
VAI00198 anti-uPA |
-/- |
-/- |
0.95/0.95 |
|
AB05 |
VAI00233 anti-LD1234 |
0.8/- |
0.8/- |
0.95/- |
|
AB06 |
VAI00243 anti-IL-1alpha |
0.99/- |
0.99/- |
0.97/0.98 |
|
AB07 |
VAI00244 anti-IGG1 |
0.94/0.95 |
0.94/0.67 |
0.87/0.74 |
|
AB08 |
VAI00245 anti-complement C3 |
0.82*/0.97 |
0.82*/- |
0.99/0.68* |
|
AB09 |
VAI00246 anti-complement C4 |
0.93/0.98 |
0.93/0.79 |
0.78/0.81 |
|
AB10 |
VAI00261 anti-VEGF |
0.84*/0.95 |
0.84*/- |
0.77/0.69 |
|
AB11 |
VAI00263 anti-alpha2-macroglobulin |
0.71/0.99 |
0.71/0.77 |
0.67/0.91 |
|
AB12 |
VAI00269 anti-IL-6 |
0.74*/- |
0.74*/- |
0.7/- |
|
AB13 |
VAI00273 anti-ceruloplasmin |
-/0.71 |
-/- |
0.98/0.87 |
|
AB14 |
VAI00274 anti-AP |
0.98/0.93 |
0.98/0.74 |
0.9/0.77 |
|
AB15 |
VAI00276 anti-Alpha-1-AT |
0.95/0.95 |
0.95/- |
0.75/0.86 |
|
AB16 |
VAI00277.1 anti-haptoglobulin |
0.96/- |
0.96/- |
0.95/0.89 |
|
AB17 |
VAI00282 anti-alpha-fetoprotein |
0.98/0.98 |
0.98/0.98 |
0.89/0.9 |
|
AB18 |
VAI00297 anti-Timp-1 |
-/- |
-/- |
0.96/0.96 |
|
AB19 |
VAI00298 anti-IGFBP-3 |
0.99/0.97 |
0.99/0.69 |
0.86/0.26* |
|
AB20 |
VAI00300 anti-IL-8 |
0.99/0.96 |
0.99/0.77 |
0.92/0.97 |
|
AB21 |
VAI00303 anti-VEGF |
0.63*/0.83 |
0.63*/0.77* |
0.66/0.87 |
|
AB22 |
VAI00305 anti-IL-6 |
-/- |
-/- |
0.93/0.95 |
|
AB23 |
VAI00307 anti-IL-2 |
0.78/0.96 |
0.78/- |
0.87/0.63 |
|
AB24 |
VAI00308 anti-TSP-1 |
0.91/0.95 |
0.91/- |
0.9/- |
|
AB25 |
VAI00338 anti-plasminogen |
0.96/- |
0.96/- |
0.88/0.89 |
|
AB26 |
VAI00339 anti-CA125 |
0.92*/- |
0.92*/- |
0.94/0.76 |
|
AB27 |
VAI00342 anti-CEA |
0.93/0.91 |
0.93/0.73 |
0.84/0.71 |
|
AB28 |
VAI00348 anti-beta2-microglobulin |
0.98/- |
0.98/- |
0.88/0.91 |
|
AB29 |
VAI00352 anti-PAI |
0.77/0.87 |
0.77/- |
0.95/0.87 |
|
AB30 |
VAI01032 anti-alpha1 ACT |
0.96/0.92 |
0.96/0.95 |
0.91/0.95 |
|
AB31 |
VAI01126 anti-albumin |
0.88/0.94 |
0.88/0.72 |
0.82/0.56* |
|
AB32 |
VAI10003 anti-IgG-Fc |
0.98/0.98 |
0.98/0.95 |
0.87/0.95 |
|
AB33 |
VAI10007 anti-hemoglobin |
0.97/0.99 |
0.97/1 |
0.87/0.8 |
|
AB34 |
VAI10011 anti-IgA |
0.92/0.99 |
0.92/0.86 |
0.88/0.97 |
|
AB35 |
VAI10013 anti-transferrin |
0.82/0.96 |
0.82/0.75 |
0.63/0.79 |
|
|
||||
|
For each antibody, the correlation between replicate sets of 24 microarrays is given, both for RCA and for direct labeling or indirect detection. The correlation is the Pearson correlation in the overlap between the sets, that is, using only samples for which measurements were available in both sets. Correlations were not calculated if the overlap between the duplicate sample sets was less than three samples or less than half the samples from one of the sets. Asterisk, not a statistically significant correlation, using a 99% confidence level based on the size of overlap between sets. |
||||
|
Zhou et al. Genome Biology 2004 5:R28 |
||||
